ArticleJACC. Case reports2024

SGLT2 Inhibitor for Cardiac Protection in a Patient With Osimertinib-Responsive Advanced EGFR-Positive Lung Cancer.

Aditya V Belamkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.